OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
8,830,303
Share change
+356,355
Total reported value
$155,197,241
Put/Call ratio
442%
Price per share
$17.58
Number of holders
82
Value change
+$6,267,898
Number of buys
51
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q1 2015

As of 31 Mar 2015, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,830,303 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, Venator Capital Management Ltd., and OXFORD ASSET MANAGEMENT. This page lists 82 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.